VANDEKOP AMY O'LEARY enters KALARIS THERAPEUTICS, INC. with 948.00 shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/27/2026ACC: 0001193125-26-318054
Officer· See Remarks
Since Jul 2026
948.00
Baseline shares
100% direct
948.00
Direct ownership
1 position
47.41K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned948.00
Total
948.00 direct948.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 948.00 | Direct |
| Total | 948.00 | 948.00 direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
27.41K
Shares owned
N/A
Exercise price
7.31
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
20K
Shares owned
N/A
Exercise price
6.81
Expiration
—
Exercise window
—
Total
Underlying
47.41K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 7.31 | — | — | 27.41K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 6.81 | — | — | 20K | N/A |
| Total | 47.41K | 0.00 | ||||